tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

VCNX Stock Latest News

Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab
The FlyVaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab
8d ago
VCNX
Vaccinex files to sell 490,509 shares of common stock for holders
PremiumThe Fly
Vaccinex files to sell 490,509 shares of common stock for holders
28d ago
VCNX
Vaccinex Completes Key Study Phase for Alzheimer’s Drug
PremiumCompany Announcements
Vaccinex Completes Key Study Phase for Alzheimer’s Drug
2M ago
8K
VCNX
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease
PremiumPress Releases
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease
2M ago
VCNX
Vaccinex reports completion of last patient visit in SIGNAL-AD Phase 1b/2 study
PremiumThe Fly
Vaccinex reports completion of last patient visit in SIGNAL-AD Phase 1b/2 study
2M ago
VCNX
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
ACIU
ADAP
option delistings on June 3rd
PremiumThe Fly
option delistings on June 3rd
2M ago
JG
AKA
Vaccinex trading resumes
PremiumThe Fly
Vaccinex trading resumes
2M ago
VCNX
Vaccinex trading halted, volatility trading pause
PremiumThe Fly
Vaccinex trading halted, volatility trading pause
2M ago
VCNX
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
2M ago
VCNX
Vaccinex reports Q1 EPS ($2.94) vs. ($20.89) last year
PremiumThe Fly
Vaccinex reports Q1 EPS ($2.94) vs. ($20.89) last year
2M ago
VCNX
Vaccinex files to sell 193,000 shares of common stock for holders
PremiumThe Fly
Vaccinex files to sell 193,000 shares of common stock for holders
3M ago
VCNX
Vaccinex files to sell 434K shares of common stock for holders
PremiumThe FlyVaccinex files to sell 434K shares of common stock for holders
4M ago
VCNX
Vaccinex reports FY23 EPS ($43.68) vs ($98.05) last year
PremiumThe Fly
Vaccinex reports FY23 EPS ($43.68) vs ($98.05) last year
4M ago
VCNX
Vaccinex Reports 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Vaccinex Reports 2023 Financial Results and Provides Corporate Update
4M ago
VCNX
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
PremiumPress Releases
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
4M ago
VCNX
Vaccinex prices 193,000 shares at $7.77 in registered direct offering
PremiumThe Fly
Vaccinex prices 193,000 shares at $7.77 in registered direct offering
4M ago
VCNX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
EQ
CLDX
Vaccinex Inc Broadens Reach with ActivMab® Technology Deals
PremiumCompany Announcements
Vaccinex Inc Broadens Reach with ActivMab® Technology Deals
5M ago
8K
VCNX
Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology
PremiumPress ReleasesVaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology
5M ago
VCNX
Vaccinex enters eight new antibody discovery agreements for use of ActivMAb
PremiumThe Fly
Vaccinex enters eight new antibody discovery agreements for use of ActivMAb
5M ago
VCNX
Vaccinex trading halted, news pending
PremiumThe Fly
Vaccinex trading halted, news pending
5M ago
VCNX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >